Goldman Sachs Group Inc Precigen, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PGEN
# of Institutions
140Shares Held
145MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$65.9 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD18.2MShares$14.4 Million1.57% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.76MShares$5.34 Million0.0% of portfolio
-
Iridian Asset Management LLC3.78MShares$2.98 Million0.8% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $164M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...